Skip to main content
. 2022 Jun;63(6):899–905. doi: 10.2967/jnumed.121.262368

FIGURE 1.

FIGURE 1.

Biodistribution of 18F-BMS986192 at baseline (n = 8) and follow-up (n = 4). In the patients with follow-up scans, 18F-BMS986192 uptake in the tonsil was significantly higher at baseline than at follow-up (Wilcoxon signed rank test, P = 0.002). There were no other differences in 18F-BMS986192 uptake between baseline and follow-up.